313 related articles for article (PubMed ID: 11792760)
21. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
Thompson KM; Tebbens RJ
Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
[TBL] [Abstract][Full Text] [Related]
22. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
23. [Cost of dialysis in France].
Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
[TBL] [Abstract][Full Text] [Related]
24. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
Yang WC; Hwang SJ;
Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
[TBL] [Abstract][Full Text] [Related]
25. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
26. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
27. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
Hattori S; Yosioka K; Honda M; Ito H;
Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
[TBL] [Abstract][Full Text] [Related]
28. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
29. Slowing the progression of chronic renal failure: economic benefits and patients' perspectives.
Trivedi HS; Pang MM; Campbell A; Saab P
Am J Kidney Dis; 2002 Apr; 39(4):721-9. PubMed ID: 11920337
[TBL] [Abstract][Full Text] [Related]
30. Strategies for improving long-term survival in patients with ESRD.
Nolan CR
J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S120-7. PubMed ID: 16251247
[TBL] [Abstract][Full Text] [Related]
31. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
[TBL] [Abstract][Full Text] [Related]
32. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
Manley HJ; Cannella CA
Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
[TBL] [Abstract][Full Text] [Related]
33. Economic evaluation of dialysis therapies.
Klarenbach S; Manns B
Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
[TBL] [Abstract][Full Text] [Related]
34. End-stage renal failure and national resources: the Brazilian experience.
Zatz R; Romão JE
Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of ESRD treated with renal dialysis in France in 2003.
Macron-Noguès F; Vernay M; Ekong E; Thiard B; Salanave B; Fender P; Allemand H
Am J Kidney Dis; 2005 Aug; 46(2):309-15. PubMed ID: 16112050
[TBL] [Abstract][Full Text] [Related]
36. Hemodialysis cost in Tehran, Iran.
Mahdavi-Mazdeh M; Zamani M; Zamyadi M; Rajolani H; Tajbakhsh K; Heidary Rouchi A; Aghighi M; Mahdavi A
Hemodial Int; 2008 Oct; 12(4):492-8. PubMed ID: 19090872
[TBL] [Abstract][Full Text] [Related]
37. End-stage renal disease and chronic kidney disease in Brazil.
Lugon JR
Ethn Dis; 2009; 19(1 Suppl 1):S1-7-9. PubMed ID: 19484865
[TBL] [Abstract][Full Text] [Related]
38. Has the incidence of end-stage renal disease in the USA and other countries stabilized?
Eggers PW
Curr Opin Nephrol Hypertens; 2011 May; 20(3):241-5. PubMed ID: 21422925
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
40. Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil.
Sesso R; da Silva CB; Kowalski SC; Manfredi SR; Canziani ME; Draibe SA; Elgazzar HA; Ferraz MB
Int J Technol Assess Health Care; 2007; 23(1):126-30. PubMed ID: 17234026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
